Motsch J, Bleser W, Ismaily A J, Distler L
Institut für Anaesthesie, Universitätskliniken des Saarlandes Homburg/Saar.
Anasth Intensivther Notfallmed. 1988 Oct;23(5):271-5.
Terminal cancer patients report substantial pain frequently. Pain control can be achieved in many patients with conventional methods and analgesics. However, significant numbers of patients remain in pain. For these patients, continuous intrathecal narcotics delivered by an external portable pump via a subcutaneous port, offer substantially improved pain control with minimal risk of serious systemic complications. Duration of treatment in our 40 cancer patients lasted up to 11 month. Continuous intrathecal morphine or fentanyl relieved pain till death due to cancer. Supraspinal side effects of opioids were only seen during the first week of intrathecal narcotic treatment. No serious complications like meningitis or other infections were observed. Postmortem examination also could not detect changes of the cord or signs of arachnoiditis due to intrathecal narcotics or the implanted catheter. We conclude, that continuous intrathecal narcotic infusion by means of small portable pump is a very efficient method to control terminal cancer pain and enables treatment on an outpatient basis until death.
晚期癌症患者经常报告有剧痛。许多患者通过传统方法和镇痛药可以实现疼痛控制。然而,仍有相当数量的患者持续疼痛。对于这些患者,通过皮下端口由外部便携式泵持续鞘内注射麻醉剂,能在将严重全身并发症风险降至最低的情况下,显著改善疼痛控制。我们的40名癌症患者的治疗持续时间长达11个月。持续鞘内注射吗啡或芬太尼可缓解疼痛直至因癌症死亡。阿片类药物的脊髓上副作用仅在鞘内麻醉治疗的第一周出现。未观察到如脑膜炎或其他感染等严重并发症。尸检也未发现因鞘内麻醉剂或植入导管导致的脊髓变化或蛛网膜炎迹象。我们得出结论,借助小型便携式泵持续鞘内注射麻醉剂是控制晚期癌症疼痛的一种非常有效的方法,并且能够在门诊进行治疗直至患者死亡。